Home
GenIbet

GenIbet Market Share Analysis for May 2026

recipharm is a world leading cdmo. supporting customers in bringing innovations to market, from early stage development to commercial manufacturing.

Industry: N/A

Domaingenibet.com

Year Founded2006

Employees51 - 200

Annual Revenue$10M - $15M

GenIbet

GenIbet (including company regionals)

genibet.com

See more website traffic and engagement information

GenIbet Revenue up to May 2026 is 10M - 15M

revenue generated by GenIbet top domains

GenIbet top domains revenue over 3 years

Revenue for GenIbet top domains

genibet.com10M - 15M

See more with Sales Intelligence

Total visits to GenIbet's top domains

Understand GenIbet market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in GenIbet's top domains

Analyze GenIbet engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on GenIbet's top domains

See how GenIbet keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

GenIbet top competitors by domain

Top similar sites in May 2026, ranked by their affinity

google.frCompany NameGoogleEmployees> 10001HQUnited States, California, Mountain ViewAnnual revenue> $1BTotal visits61.9MComputers Electronics and Technology > Search Engines

Top technologies used by GenIbet

These are the website technologies, by industry, used by GenIbet top domains

Widget (3)

reCAPTCHA

Advertising (2)

Google Adsense

Mobile (2)

Meta Viewport

Audio Video Media (1)

YouTube

More Technologies

4

See all

News & Signals from GenIbet

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRecipharm acquired GenIbet Biopharmaceuticals on Jan 1st '22.Sweden-headquartered contract development and manufacturing organization Recipharm today announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome.

NewsGenIbet Biopharmaceuticals receives award Municipal Gold Medal of Merit.GenIbet Biopharmaceuticals was awarded the Municipal Gold Medal of Merit by the Oeiras Municipality.